R & D
Headed by a strong pool of 400+ scientists and researchers, R & D activities are at the core of Intas. Its constant quest for developing new products and technology has led breakthrough innovations in a wide spectrum of research areas. In last 3 years, Intas has filed 50+ formulation patents in its credit.
Intas has extensively worked on Para IV and 505 (b) 2 products for USA market and a few products are already developed and filed with USFDA. Intas targets to file 3-5 Para IV application to US market from 2011 onwards.
Intas has developed few products with lipid-based NDDS platform technology, which has resulted in three pharmaceutical formulations that are being commercialized in India. Studies to extend these products into international markets are under progress.
The Research laboratories are well equipped with sophisticated equipments to support analytical challenges meet ICH guidelines confirming the product quality. Intas has the capabilities to handle various types of reactions and resolve the analytical method related issues which shortens the development timeline cost effectively.
Intas's R & D strategies are focused on 2 major areas:
1. Pharmaceutical formulation development
2. API development